The role of IGFBP7 in the pathogenesis of MS remains largely unknown, and according to the GO analysis of IGFBP7 in MS, we suspected the possible pathogenesis involves post-translational protein modification. The gene discussed is IGFBP7; the disease is myeloid sarcoma.